Diplegic Cerebral Palsy and Action Observation Training

NCT ID: NCT05209282

Last Updated: 2024-02-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

39 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-01

Study Completion Date

2022-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, video-based action observation training and live action observation training in children with spastic diplegic cerebral palsy; It was aimed to examine the effect on motor function, activity participation and secondary outcome measures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study was designed as a single-blind randomized controlled trial. Patients aged 5-14 years with spastic diplegic cerebral palsy will be included. Children will be assigned to groups through stratified randomisation; The patients will be divided into 3 groups as experimental and control groups. Group 1 (experiment): video-based action observation training in addition to the conventional rehabilitation program, Group 2 (experiment): live action observation training in addition to the conventional rehabilitation program, Group 3 (control) will receive only the conventional rehabilitation program. The experimental group will receive 20 minutes of action observation training after a conventional physiotherapy program for 20 minutes for 8 weeks, 40 minutes 2 days a week. The control group will receive 40 minutes of conventional treatment. Evaluations will be made for each group, before and 8 weeks after the start of the study. GMFM for gross motor function; Pediatric berg balance scale for balance function; Timed Up and Go Test for functional mobility assessment; Gillette Functional Assessment Questionnaire and 1-min walk test to assess functional walking; sit and stand test for functional muscle strength and to evaluate activity participation; The Child and Adolescent Participation Questionnaire (CASP) will be used.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diplegic Cerebral Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Experimental, Randomized Controlled Study
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Grup I

Conventional physiotherapy program, Video-based action observation training

Group Type EXPERIMENTAL

Video Based Action Observation

Intervention Type OTHER

Individuals in this group will receive video-based action observation training in addition to the conventional physiotherapy program.

Conventional physiotherapy program

Intervention Type OTHER

Individuals in this group will only receive a conventional physiotherapy program.

Grup II

Conventional physiotherapy program, Live Action Observation Training

Group Type EXPERIMENTAL

Live Action Observation

Intervention Type OTHER

Individuals in this group will receive live action observation training in addition to the conventional physiotherapy program.

Conventional physiotherapy program

Intervention Type OTHER

Individuals in this group will only receive a conventional physiotherapy program.

Grup III

Conventional physiotherapy program

Group Type OTHER

Conventional physiotherapy program

Intervention Type OTHER

Individuals in this group will only receive a conventional physiotherapy program.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Video Based Action Observation

Individuals in this group will receive video-based action observation training in addition to the conventional physiotherapy program.

Intervention Type OTHER

Live Action Observation

Individuals in this group will receive live action observation training in addition to the conventional physiotherapy program.

Intervention Type OTHER

Conventional physiotherapy program

Individuals in this group will only receive a conventional physiotherapy program.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Conventional physiotherapy program Conventional physiotherapy program

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being diagnosed with spastic diplegic cerebral palsy,
* To be between the ages of 5-14,
* To be at GMFCS I, II and III levels,
* To have the cognitive level to follow the instructions given by the researchers,
* IQ\> 70 (to be accessed from patient files),
* Those who do not have serious restrictions in joint movement,

Exclusion Criteria

* Children with joint contractures,
* Not having visual impairment and visual field defect,
* Children who have had a seizure in the last 6 months or children who cannot be controlled despite seizure medication
* Those who received botulinum injections 6 months before the study.
Minimum Eligible Age

5 Years

Maximum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Inonu University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Burcu Talu

Assoc.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Burcu TALU, Assoc. Prof.

Role: PRINCIPAL_INVESTIGATOR

Inonu University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Inonu University

Malatya, Battalgazi/MALATYA, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021/2663

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.